Humoral and Cellular Responses to a Fifth Bivalent SARS-CoV-2 Vaccine Dose in Patients with Immune-Mediated Inflammatory Diseases on Tumour Necrosis Factor Inhibitors: a Prospective Cohort Study
LANCET REGIONAL HEALTH-EUROPE(2025)
Key words
SARS-CoV-2,Vaccination,COVID-19,TNF inhibitors,Tumour necrosis factor inhibitor,T cells,Neutralising antibodies,Inflammatory arthritis,Inflammatory bowel disease
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined